EVENTS CALENDAR

Board of Directors

PIA-PR 2017-2018 Board of Directors

The PIA-PR Board of Directors is composed of eleven members, represented by a top executive in Puerto Rico. Five of these members represent the manufacturing sector and six represent the commercial sector. In addition, there are three ex-officio members: the PIA-PR Operations Vice President, PIA-PR Legal Counselor, and PIA-PR Advisor to the Board

PIA-PR gathers and represents research-based multinational pharmaceutical and biotechnology companies with operations on the island. These are 13 corporations organized in 21 manufacturing operations with 13 commercial entities. The biopharmaceutical industry represents 26.5% of the island's Gross Domestic Product 60% of all island imports and 98% of all island exports. The biopharmaceutical industry in Puerto Rico generates over 78,000 jobs on the island: 18,000 direct and 60,000 indirect.

 

Chairperson

 Wendy Perry

 Managing Director   

 Merck Commercial Operations

 

 

Vice-Chair

 

  Ileana Quiñónes 

  VP & GM

  IPR Pharmaceuticals (AstraZeneca)

 

 

Secretary

 

 Elsa Saavedra 

 General Manager

 AstraZeneca (Commercial)

 

 

Treasurer

 

 David L. Thompson

 General Manager

 AbbVie (Manufacturing)

 

 

Directors

 

 Andrew Willy 

 General Manager 

 Amgen (Commercial) 

 

 Jorge López

 VP & General Manager 

 Bristol Myers Squibb (Manufacturing)

 

 

  

Victor Cruz

 VP & General Manager 

 Lilly (Manufacturing)

 

 Brenda Torres 

 VP Drug Products                

 Amgen (Manufacturing)

 

 

 José Viera 

 General Manager 

 Allergan (Commercial)

 

 

 

Ex-Officio

Board Members

 

Rafael Castro   

VP Operations

 

 

 

 

 

Eduardo M. Negrón-Navas   

Legal Counsel 

Eduardo Negrón Law

 

Iván Román   

Advisor to the Board

Stratech, LLC